Fusion Pharmaceuticals Inc. Total Liabilities
Fusion Pharmaceuticals Inc. had Total Liabilities of $81.98 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2024-05-07
- 2024-03-31: Liabilities $81.98M.
- 2023-12-31: Liabilities $63.36M.
- 2023-09-30: Liabilities $64.91M.
- 2023-06-30: Liabilities $65.33M.
| Period end | Liabilities |
|---|---|
| 2024-03-31 | $81.98M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $63.36M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $64.91M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $65.33M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $65.72M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $56.84M 10-K · filed 2024-03-20 |
| 2022-09-30 | $55.35M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $29.23M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $20.53M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $20.82M 10-K · filed 2023-03-16 |
| 2021-09-30 | $21.81M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $18.61M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $18.24M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $16.16M 10-K · filed 2022-03-17 |
| 2020-09-30 | $5.61M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $7.90M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $10.34M 10-K · filed 2021-03-25 |